Veranex

company

About

Veranex is an end-to-end, global, tech-enabled, concept-through-commercialization service provider focuses on medical technology.

  • Raleigh,North Carolina,United States
  • 501 - 1000

Details

Last Funding Type
Private Equity(PE)
Industries
Health Care,Health Diagnostics,Information Services,Medical Device
Founded date
Jan 1, 2021
Number Of Employee
501 - 1000
Operating Status
Active
Also Known As
Veranex solutions

Veranex is the first truly end-to-end, global, tech-enabled, concept-through-commercialization service provider that focuses solely on medical technology: medical device, diagnostics, companion diagnostics, digital health, and drug delivery. For all your needs through the entire medical device clinical trial process, Veranex is transforming medtech innovations.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
Veranex has raised a total of — in funding over 2 rounds. Their latest funding was raised on May 18, 2022 from a Private Equity(PE) round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 18, 2022 Private Equity(PE) 3 Detail
Jun 16, 2021 Private Equity(PE) 1 Summit Partners Detail

Investors

Number of Lead Investors
Number of Investors
1
3
Veranex is funded by 3 investors. Accelmed and Lauxera Capital Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Accelmed Private Equity(PE)
Lauxera Capital Partners Private Equity(PE)
Summit Partners Private Equity(PE)

Employee Profiles

Number of Employee Profiles
9
Veranex has 9 current employee profiles, including Executive Luis T. Gutierrez
Executive
Executive
Executive
Executive
Executive

Acquisition

Veranex has acquired 13 organizations. Their most recent acquisition was Ximedica on Jun 16, 2021. They acquired Ximedica for 0.

Date Company Name
Industry Acquisition Type Price
Jun 16, 2021 Ximedica
Health Diagnostics acquisition Detail
Jun 16, 2021 Boston Healthcare
Biotechnology acquisition Detail
Jun 16, 2021 Quartesian
Education acquisition Detail
Aug 3, 2021 Experien Group
Health Care acquisition Detail
Oct 12, 2021 IMMR
Biotechnology acquisition Detail